Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.

Go back to Resources

Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool.

Go back to Resources

A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements (CDE]): What They Are, Ways to Use Them, and Gaps, Mini-Symposium

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements (CDE]): What They Are, Ways to Use Them, and Gaps, Mini-Symposium

Authors:

Secondary:

Location:

Publisher:

URL:

Abstract:

Go back to Resources

Pain Matters! NINDS Cerebral Palsy Common Data Elements, International Classification of Functioning, And Measures of Pain in Children With Cerebral Palsy, Mini-Symposium

Go back to Resources

Pain Matters! NINDS Cerebral Palsy Common Data Elements, International Classification of Functioning, And Measures of Pain in Children With Cerebral Palsy, Mini-Symposium

Authors:

Secondary:

URL:

Go back to Resources

Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.

Go back to Resources

Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Baricitinib versus Dexamethasone for Adults Hospitalised with COVID-19 (ACTT-4): a Randomised, Double-blind, Double Placebo-controlled Trial

Go back to Resources

Baricitinib versus Dexamethasone for Adults Hospitalised with COVID-19 (ACTT-4): a Randomised, Double-blind, Double Placebo-controlled Trial

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The Antibody Landscapes Following AS03 and MF59 Adjuvanted H5N1 Vaccination

Go back to Resources

The Antibody Landscapes Following AS03 and MF59 Adjuvanted H5N1 Vaccination

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Abstract:

Go back to Resources

Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults

Go back to Resources

Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cT) cells and antibody responses.

Go back to Resources

An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cT) cells and antibody responses.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Expanding access to early phase trials: the CATCH-UP.2020 experience.

Go back to Resources

Expanding access to early phase trials: the CATCH-UP.2020 experience.

Authors:

Secondary:

Volume:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions